Malignant Brain Stem Neoplasm — Trials

Malignant Brain Stem Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 49
Recruiting: 26
Ph III recruiting: 1
Growth YoY: —
Industry share: 14%
Top sponsor: Nationwide Children's Hospital
Termination share: 38.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (19)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07644312	Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG	not yet recruiting	Phase 2	12	Nationwide Children's HospitalOTHER	0	Sep 9, 2026	clinicaltrials
NCT07501156	H3K27M-specific Immune Effector Cells Targeting DMG/DIPG	not yet recruiting	Phase 1 / Phase 2	30	Shenzhen Geno-Immune Medical InstituteOTHER	1	Aug 27, 2026	clinicaltrials